Predicting the risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma
The mechanisms of the hypercoagulable state in cirrhotics with and without hepatocellular carcinoma are incompetently comprehended. Objective: We aimed to explore the plasma Annexin A5/PS + MP ratio in these patients. Higher levels of Annexin A5 and PhosphatidylSerine bearing microparticles have bee...
Main Authors: | Waleed Mohamed Serag, Bedoor Shehap eldeen Mohammed, Magdy Mahmoud Mohamed, Basem Eysa Elsayed |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-08-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844020315218 |
Similar Items
-
Annexin A5 as a marker for hepatocellular carcinoma in cirrhotic hepatitis C virus patients
by: Waleed Mohamed Serag, et al.
Published: (2021-05-01) -
Transient portal vein thrombosis in liver cirrhosis
by: Xingshun Qi, et al.
Published: (2018-06-01) -
Detection of liver fibrosis stages in patients with hepatitis C virus infection by non-invasive tool
by: Waleed Mohamed Serag, et al.
Published: (2021-01-01) -
Deep Vein Thrombosis is Not Uncommon in India
by: Edwin Stephen, et al.
Published: (2017-01-01) -
Olga Ivanovna Urazova
by: Article Editorial
Published: (2009-06-01)